TD Asset Management’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.71M | Buy |
103,066
+19,855
| +24% | +$715K | ﹤0.01% | 806 |
|
|
2025
Q1 | $2.59M | Buy |
83,211
+27,718
| +50% | +$863K | ﹤0.01% | 906 |
|
|
2024
Q4 | $1.42M | Buy |
55,493
+10,499
| +23% | +$268K | ﹤0.01% | 1071 |
|
|
2024
Q3 | $1.27M | Buy |
44,994
+822
| +2% | +$23.2K | ﹤0.01% | 1148 |
|
|
2024
Q2 | $1.16M | Sell |
44,172
-24,880
| -36% | -$656K | ﹤0.01% | 1133 |
|
|
2024
Q1 | $2.1M | Sell |
69,052
-151,131
| -69% | -$4.59M | ﹤0.01% | 1008 |
|
|
2023
Q4 | $6.18M | Sell |
220,183
-70,300
| -24% | -$1.97M | 0.01% | 710 |
|
|
2023
Q3 | $7.88M | Buy |
290,483
+96,026
| +49% | +$2.61M | 0.01% | 630 |
|
|
2023
Q2 | $5.98M | Sell |
194,457
-7,856
| -4% | -$241K | 0.01% | 703 |
|
|
2023
Q1 | $7.29M | Buy |
202,313
+996
| +0.5% | +$35.9K | 0.01% | 668 |
|
|
2022
Q4 | $7.96M | Buy |
201,317
+9,888
| +5% | +$391K | 0.01% | 645 |
|
|
2022
Q3 | $7.72M | Sell |
191,429
-14,348
| -7% | -$579K | 0.01% | 653 |
|
|
2022
Q2 | $8.65M | Buy |
205,777
+37,742
| +22% | +$1.59M | 0.01% | 642 |
|
|
2022
Q1 | $6.55M | Buy |
168,035
+628
| +0.4% | +$24.5K | 0.01% | 760 |
|
|
2021
Q4 | $6.67M | Buy |
167,407
+12,915
| +8% | +$515K | 0.01% | 793 |
|
|
2021
Q3 | $5.58M | Sell |
154,492
-1,000
| -0.6% | -$36.1K | 0.01% | 792 |
|
|
2021
Q2 | $5.94M | Buy |
155,492
+2,500
| +2% | +$95.5K | 0.01% | 788 |
|
|
2021
Q1 | $6.67M | Buy |
152,992
+5,800
| +4% | +$253K | 0.01% | 753 |
|
|
2020
Q4 | $7.37M | Sell |
147,192
-111,699
| -43% | -$5.59M | 0.01% | 684 |
|
|
2020
Q3 | $10.9M | Buy |
258,891
+70,000
| +37% | +$2.95M | 0.02% | 521 |
|
|
2020
Q2 | $9.17M | Buy |
+188,891
| New | +$9.17M | 0.01% | 530 |
|